Development and external validation of a nomogram to predict overall survival following stereotactic body radiotherapy for early-stage lung cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Development and external validation of a nomogram to predict overall survival following stereotactic body radiotherapy for early-stage lung cancer ; volume:15 ; number:1 ; day:22 ; month:4 ; year:2020 ; pages:1-11 ; date:12.2020
Radiation oncology ; 15, Heft 1 (22.4.2020), 1-11, 12.2020
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Baker, Sarah
Bakunina, Katerina
Duijm, Marloes
Hoogeman, Mischa S.
Cornelissen, Robin
Antonisse, Imogeen
Praag, John
Heemsbergen, Wilma D.
Nuyttens, Joost Jan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13014-020-01537-z
- URN
-
urn:nbn:de:101:1-2020070401050310202283
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Baker, Sarah
- Bakunina, Katerina
- Duijm, Marloes
- Hoogeman, Mischa S.
- Cornelissen, Robin
- Antonisse, Imogeen
- Praag, John
- Heemsbergen, Wilma D.
- Nuyttens, Joost Jan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation
Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer
Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer
Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry
Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapy
Development and Validation of a Nomogram for Patients with Nonmetastatic BCLC Stage C Hepatocellular Carcinoma after Stereotactic Body Radiotherapy
Predictors of Radiotherapy Induced Bone Injury (RIBI) after stereotactic lung radiotherapy
Online adaptive radiotherapy in stereotactic body radiotherapy for pancreatic cancer patients
Benchmarking techniques for stereotactic body radiotherapy for early-stage glottic laryngeal cancer: LINAC-based non-coplanar VMAT vs. Cyberknife planning
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation
Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer
Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer
Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry
Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapy
Development and Validation of a Nomogram for Patients with Nonmetastatic BCLC Stage C Hepatocellular Carcinoma after Stereotactic Body Radiotherapy
Predictors of Radiotherapy Induced Bone Injury (RIBI) after stereotactic lung radiotherapy
Online adaptive radiotherapy in stereotactic body radiotherapy for pancreatic cancer patients
Benchmarking techniques for stereotactic body radiotherapy for early-stage glottic laryngeal cancer: LINAC-based non-coplanar VMAT vs. Cyberknife planning
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation
Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer
Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer
Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry
Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapy
Development and Validation of a Nomogram for Patients with Nonmetastatic BCLC Stage C Hepatocellular Carcinoma after Stereotactic Body Radiotherapy
Predictors of Radiotherapy Induced Bone Injury (RIBI) after stereotactic lung radiotherapy
Online adaptive radiotherapy in stereotactic body radiotherapy for pancreatic cancer patients